Logo

TransTech Pharma Selects Genedata s High Throughput Screener

Dec 14, 2005

NEW YORK, Dec. 14 (GenomeWeb News) - TransTech Pharma signed a multi-year license for Genedata's high throughput screening-analysis software, Genedata said today.

 

TransTech Pharma scientists will use the software, Genedata Screener, to enhance their efforts to develop small molecules as therapeutics for treating human diseases. Screener has been integrated with TransTech Pharma's IT and screening infrastructure to automate data quality evaluation and standardize the analysis of compound bioactivity.

 

Financial details were not disclosed.

Breaking News
The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.